A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants

類似資料

• Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
  著者:: Naveena Aloysia D'Cor, 等
  出版事項: (2023-01-01)
• A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine
  著者:: Dalvi, Shashank, 等
  出版事項: (2015)
• Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem(®) demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine
  著者:: Aspinall, Sanet, 等
  出版事項: (2012)
• Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants
  著者:: Gandhi, Dulari J., 等
  出版事項: (2015)
• Diphtheria immunogenicity following the administration of pentavalent DTwP-HB-Hib vaccine at 4- and 8-week intervals: A randomized controlled trial
  著者:: Ariesti Karmila, 等
  出版事項: (2025-09-01)